{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T16:26:26Z","timestamp":1787415986606,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010823","name":"Tore Nilson Foundation for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022654","name":"The Skin Fund Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022654","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Region Stockholm","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100024172","name":"Schleswig-Holstein","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100024172","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejca.2026.116949","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:25:13Z","timestamp":1783725913000},"page":"116949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Vitiligo and skin cancer risk across racial\/ethnic groups: A retrospective propensity score-matched study on 123,179 patients"],"prefix":"10.1016","volume":"245","author":[{"given":"Yasmin","family":"Nazzal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4333-2289","authenticated-orcid":false,"given":"Maria","family":"Najeeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9184-3178","authenticated-orcid":false,"given":"Jason","family":"Dagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0797-6570","authenticated-orcid":false,"given":"Thierry","family":"Passeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf J.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2051-8491","authenticated-orcid":false,"given":"Philip","family":"Curman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejca.2026.116949_bib1","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","article-title":"A review of the worldwide prevalence of vitiligo in children\/adolescents and adults","volume":"51","author":"Kr\u00fcger","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ejca.2026.116949_bib2","doi-asserted-by":"crossref","DOI":"10.1007\/s40257-026-01012-7","article-title":"Exposome risk factors for vitiligo: a systematic evidence review","author":"Piquero-Casals","year":"2026","journal-title":"Am J Clin Dermatol"},{"issue":"4s2","key":"10.1016\/j.ejca.2026.116949_bib3","article-title":"Clinical features of vitiligo and social impact on quality of life","volume":"13","author":"Seneschal","year":"2023","journal-title":"Dermatol Pract Concept"},{"issue":"1","key":"10.1016\/j.ejca.2026.116949_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41572-025-00670-x","article-title":"Vitiligo","volume":"11","author":"Seneschal","year":"2025","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.ejca.2026.116949_bib5","doi-asserted-by":"crossref","DOI":"10.5826\/dpc.1304S2a313S","article-title":"Vitiligo: current therapies and future treatments","author":"Seneschal","year":"2023","journal-title":"Dermatol Pract Concept"},{"issue":"4","key":"10.1016\/j.ejca.2026.116949_bib6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jamadermatol.2024.5737","article-title":"Combination of Baricitinib and phototherapy in adults with active vitiligo: a randomized clinical trial","volume":"161","author":"Seneschal","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2026.116949_bib7","article-title":"Efficacy and safety of ruxolitinib cream combined with narrow-band UVB phototherapy for treatment of vitiligo","author":"Pandya","year":"2025","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.ejca.2026.116949_bib8","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3892\/etm.2021.9743","article-title":"Novel immunological and genetic factors associated with vitiligo: A review","volume":"21","author":"Said-Fernandez","year":"2021","journal-title":"Exp Ther Med"},{"issue":"2","key":"10.1016\/j.ejca.2026.116949_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.det.2016.11.003","article-title":"Skin Cancer Risk (Nonmelanoma Skin Cancers\/Melanoma) in Vitiligo Patients","volume":"35","author":"Rodrigues","year":"2017","journal-title":"Dermatol Clin"},{"issue":"10","key":"10.1016\/j.ejca.2026.116949_bib10","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1007\/s13555-025-01520-0","article-title":"Cancer Risk in Vitiligo: No Evidence of Increased Prevalence-A Systematic Review and Meta-analysis","volume":"15","author":"Mohammed","year":"2025","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"11","key":"10.1016\/j.ejca.2026.116949_bib11","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.jid.2023.04.013","article-title":"Risk of melanoma and nonmelanoma skin cancer in people with vitiligo: United Kingdom population-based cohort study","volume":"143","author":"Ferguson","year":"2023","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.ejca.2026.116949_bib12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jid.2023.08.012","article-title":"The Risk of Keratinocyte Cancer in Vitiligo and the Potential Mechanisms Involved","volume":"144","author":"Rooker","year":"2024","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.ejca.2026.116949_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/bjd\/ljaf074","article-title":"Incidence, stage and outcome of malignant melanoma, keratinocyte and other cancers in individuals with vitiligo or alopecia: intraindividual or familial risks?","volume":"193","author":"Delcoigne","year":"2025","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.ejca.2026.116949_bib14","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jaad.2014.07.050","article-title":"Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo","volume":"71","author":"Paradisi","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.ejca.2026.116949_bib15","doi-asserted-by":"crossref","first-page":"20195","DOI":"10.1038\/s41598-021-99786-9","article-title":"Reduced risk of skin cancer and internal malignancies in vitiligo patients: a retrospective population-based cohort study in Taiwan","volume":"11","author":"Weng","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ejca.2026.116949_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jdin.2020.03.004","article-title":"Risk of skin cancer in patients with vitiligo in Denmark: A nationwide cohort study","volume":"1","author":"J\u00f8rgensen","year":"2020","journal-title":"JAAD Int"},{"issue":"1","key":"10.1016\/j.ejca.2026.116949_bib17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/bjd.12111","article-title":"Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners","volume":"168","author":"Teulings","year":"2013","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.ejca.2026.116949_bib18","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/ced.15010","article-title":"Risk of skin cancer after ultraviolet phototherapy in patients with vitiligo: a systematic review and meta-analysis","volume":"47","author":"Wu","year":"2022","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.ejca.2026.116949_bib19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jamadermatol.2020.0218","article-title":"Evaluation for Skin Cancer and Precancer in Patients With Vitiligo Treated With Long-term Narrowband UV-B Phototherapy","volume":"156","author":"Bae","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.ejca.2026.116949_bib20","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jaad.2008.09.033","article-title":"Incidence of nonmelanoma skin cancer in a cohort of patients with vitiligo","volume":"60","author":"Hexsel","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.ejca.2026.116949_bib21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/bjd.18247","article-title":"The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea","volume":"182","author":"Kim","year":"2020","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.ejca.2026.116949_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15091847","article-title":"Cancer risks in vitiligo patients: a nationwide population-based study in Taiwan","volume":"15","author":"Li","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ejca.2026.116949_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1516126","article-title":"A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX","volume":"16","author":"Ludwig","year":"2025","journal-title":"Front Pharmacol"},{"issue":"9596","key":"10.1016\/j.ejca.2026.116949_bib24","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2026.116949_bib25","article-title":"Increased risk of skin cancer in mastocytosis: A large-scale retrospective cohort study of over 20,000 patients","author":"Bergstr\u00f6m","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2026.116949_bib26","article-title":"Increased risk of skin cancers in mucous membrane pemphigoid: a large-scale matched cohort study of 117 million US individuals","volume":"12","author":"Nouri","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ejca.2026.116949_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2026.01.064","article-title":"Rethinking the role of null findings in dermatologic research","author":"Curman","year":"2026","journal-title":"J Am Acad Dermatol"},{"issue":"18","key":"10.1016\/j.ejca.2026.116949_bib28","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJMoa0908547","article-title":"Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo","volume":"362","author":"Jin","year":"2010","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ejca.2026.116949_bib29","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1200\/JCO.18.01223","article-title":"Markedly reduced risk of internal malignancies in patients with vitiligo: a nationwide population-based cohort study","volume":"37","author":"Bae","year":"2019","journal-title":"J Clin Oncol"},{"issue":"35","key":"10.1016\/j.ejca.2026.116949_bib30","doi-asserted-by":"crossref","first-page":"eabn9299","DOI":"10.1126\/sciadv.abn9299","article-title":"Altered epidermal proliferation, differentiation, and lipid composition: Novel key elements in the vitiligo puzzle","volume":"8","author":"Kovacs","year":"2022","journal-title":"Sci Adv"},{"issue":"17","key":"10.1016\/j.ejca.2026.116949_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13175225","article-title":"Vitiligo: from pathogenesis to treatment","volume":"13","author":"Speeckaert","year":"2024","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.ejca.2026.116949_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00403-024-02942-0","article-title":"Perception of skin cancer risk and sun protective practices in individuals with vitiligo: a prospective international cross-sectional survey","volume":"316","author":"Gonzalez","year":"2024","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"10.1016\/j.ejca.2026.116949_bib33","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/bjd\/ljac046","article-title":"Photoprotection for people with skin of colour: needs and strategies","volume":"188","author":"Krutmann","year":"2023","journal-title":"Br J Dermatol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926007306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926007306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T16:18:43Z","timestamp":1787415523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926007306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":33,"alternative-id":["S0959804926007306"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116949","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitiligo and skin cancer risk across racial\/ethnic groups: A retrospective propensity score-matched study on 123,179 patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116949"}}